Medicines, Poisons and Therapeutic Goods Act 2022
127Regulatory Advisory Committee
Start here
Get a plain-English read of 127
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Act 2022.
127 Regulatory Advisory Committee
127 Regulatory Advisory Committee
(1) The Regulatory Advisory Committee is established by this Act.
(2) The function of the Committee is to advise the Health Secretary on matters referred to it by the Health Secretary relating to the following—
(a) the operation, administration or amendment of this Act, the regulations and the NSW Poisons Schedules, including proposals to make, alter or repeal the regulations,
(b) therapeutic goods or stock medicines,
(c) the scheduling of substances under the Commonwealth Therapeutic Goods Act.
(3) The Committee also has other functions conferred or imposed on it by or under this Act or another Act.
(4) The Committee must consist of not less than 9, and not more than 15, members appointed by the Health Secretary.
(5) The Health Secretary must appoint the following—
(a) a person nominated by the Commissioner of Police,
(b) a person nominated by SafeWork NSW,
(c) a person nominated by the Australian Medical Association,
(d) a person nominated by the New South Wales branch of the Pharmacy Guild of Australia,
(e) a person nominated by the New South Wales branch of the Pharmaceutical Society of Australia.
(6) The Health Secretary may appoint persons who the Health Secretary considers have qualifications or experience in the following areas—
(a) medical, dental, nursing and midwifery,
(b) veterinary practice,
(c) industrial use of scheduled substances, including in primary industry,
(d) pharmacology,
(e) toxicology,
(f) the medicines manufacturing and distribution industries,
(g) the development of medicines and the regulation of scheduled substances, including their registration as therapeutic goods under the Commonwealth Therapeutic Goods Act,